{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:02:38Z","timestamp":1761541358865,"version":"build-2065373602"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.cgh.2006.03.004","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T02:30:33Z","timestamp":1146796233000},"page":"548-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetics of Hepatobiliary Diseases"],"prefix":"10.1016","volume":"4","author":[{"given":"Brian D.","family":"Juran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2006.03.004_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.289.8.989","article-title":"Alcohol consumption and expenditures for underage drinking and adult excessive drinking","volume":"289","author":"Foster","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2006.03.004_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/hep.20972","article-title":"Research opportunities on alcohol and liver damage","volume":"42","author":"Zakhari","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1471-4914(01)02096-2","article-title":"Alcoholic liver disease","volume":"7","author":"Stewart","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cgh.2006.03.004_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","article-title":"Cytochrome P-4502E1","volume":"77","author":"Lieber","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cgh.2006.03.004_bib5","series-title":"Alcoholic liver disease","first-page":"89","article-title":"The role of acetaldehyde adducts in liver injury","author":"Tuma","year":"1995"},{"key":"10.1016\/j.cgh.2006.03.004_bib6","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.2741\/Niemela","article-title":"Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress","volume":"4","author":"Niemela","year":"1999","journal-title":"Front Biosci"},{"key":"10.1016\/j.cgh.2006.03.004_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib8","first-page":"1438","article-title":"Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts","volume":"21","author":"Yokoyama","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib9","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1530-0277.1996.tb01695.x","article-title":"Genetic predisposition to organ-specific endpoints of alcoholism","volume":"20","author":"Reed","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2006.03.004_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.1840130611","article-title":"Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes","volume":"13","author":"Enomoto","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-199808000-00007","article-title":"The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians","volume":"8","author":"Grove","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cgh.2006.03.004_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.alcalc.a008303","article-title":"Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease","volume":"32","author":"Whitfield","year":"1997","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cgh.2006.03.004_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510260119","article-title":"Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis","volume":"26","author":"Grove","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/alcalc\/agh047","article-title":"Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients","volume":"39","author":"Valenti","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.cgh.2006.03.004_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.46.4.540","article-title":"Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease","volume":"46","author":"Grove","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11894-005-0051-8","article-title":"Epidemiology and risk factors for gallstone disease","volume":"7","author":"Shaffer","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2006.03.004_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1590-8658(03)00009-4","article-title":"Pathways of cholesterol crystallization in model bile and native bile","volume":"35","author":"Portincasa","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2006.03.004_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/hep.20776","article-title":"Is the FXR the fix for cholesterol gallstone disease?","volume":"42","author":"Juran","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/er.2000-0035","article-title":"Bile acid regulation of gene expression","volume":"23","author":"Chiang","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cgh.2006.03.004_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2006.03.004_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.20654","article-title":"Genetic and environmental influences on symptomatic gallstone disease","volume":"41","author":"Katsika","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib23","series-title":"The genetic basis of common disease","first-page":"298","article-title":"Gallstones","author":"Paigen","year":"2002"},{"key":"10.1016\/j.cgh.2006.03.004_bib24","first-page":"189","article-title":"[Epidemiology of gallbladder calculi in young females]","volume":"20","author":"Pannwitz","year":"1990","journal-title":"Leber Magen Darm"},{"key":"10.1016\/j.cgh.2006.03.004_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0016-5085(03)00898-9","article-title":"ABCB4 gene mutation-associated cholelithiasis in adults","volume":"125","author":"Rosmorduc","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2004.04.065","article-title":"Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11","volume":"127","author":"van Mil","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cgh.2006.03.004_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/gast.2001.20878","article-title":"Chromosomal organization of candidate genes involved in cholesterol gallstone formation","volume":"120","author":"Lammert","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00335-004-2446-5","article-title":"Single and interacting QTLs for cholesterol gallstones revealed in an intercross between mouse strains NZB and SM","volume":"16","author":"Lyons","year":"2005","journal-title":"Mamm Genome"},{"key":"10.1016\/j.cgh.2006.03.004_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0016-5085(96)70023-9","article-title":"Apolipoprotein E polymorphism and gallstones","volume":"111","author":"Bertomeu","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/gut.44.4.557","article-title":"The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects","volume":"44","author":"Niemi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-2275(20)40064-1","article-title":"Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease","volume":"36","author":"Juvonen","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cgh.2006.03.004_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/500274","article-title":"A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans","volume":"78","author":"Puppala","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cgh.2006.03.004_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncpgasthep0257","article-title":"Mechanisms of disease","volume":"2","author":"Lammert","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.03.004_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0676.1995.tb00110.x","article-title":"Prediction of prognosis of primary biliary cirrhosis in Japan","volume":"15","author":"Inoue","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.cgh.2006.03.004_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2006.03.004_bib39","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","article-title":"Primary biliary cirrhosis","volume":"40","author":"Abdulkarim","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib42","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a betaretrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2006.03.004_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","article-title":"Familial primary biliary cirrhosis reassessed","volume":"30","author":"Jones","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1542-3565(04)00678-0","article-title":"From bases to basis","volume":"3","author":"Invernizzi","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib47","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.1840070516","article-title":"Primary biliary cirrhosis","volume":"7","author":"Gores","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.48.3.397","article-title":"HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis","volume":"48","author":"Donaldson","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib49","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.1840160616","article-title":"Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype","volume":"16","author":"Underhill","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1034\/j.1399-0039.2002.590504.x","article-title":"HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis","volume":"59","author":"Wassmuth","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cgh.2006.03.004_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(00)80213-5","article-title":"CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis","volume":"32","author":"Agarwal","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.004_bib54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib55","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib57","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib58","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib59","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib60","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0016-5085(83)80085-7","article-title":"Familial occurrence of primary sclerosing cholangitis and ulcerative colitis","volume":"85","author":"Quigley","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","article-title":"Association of primary sclerosing cholangitis with HLA-B8","volume":"24","author":"Chapman","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.1840130119","article-title":"Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cgh.2006.03.004_bib65","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.004_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/gast.2001.25527","article-title":"A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis","volume":"121","author":"Satsangi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib67","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib68","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.gene.6364113","article-title":"CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis","volume":"5","author":"Eri","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.cgh.2006.03.004_bib69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","article-title":"Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib70","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI0216787","article-title":"Liver injury in alpha1-antitrypsin deficiency","volume":"110","author":"Perlmutter","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cgh.2006.03.004_bib71","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.004_bib72","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.20815","article-title":"Alpha-1-antitrypsin deficiency","volume":"42","author":"Rudnick","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib73","first-page":"514","article-title":"The liver in adolescents with alpha 1-antitrypsin deficiency","volume":"22","author":"Sveger","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib74","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cld.2004.06.001","article-title":"Alpha-1-antitrypsin deficiency","volume":"8","author":"Perlmutter","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2006.03.004_bib75","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00175.2003","article-title":"Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency","volume":"286","author":"Teckman","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2006.03.004_bib76","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840400404","article-title":"Polycystic disease of the liver","volume":"40","author":"Everson","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.004_bib78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib79","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib80","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/316904","article-title":"Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1","volume":"67","author":"Reynolds","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cgh.2006.03.004_bib81","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.cgh.2006.03.004_bib82","first-page":"1013","article-title":"Cell activation by glycated proteins","volume":"44","author":"Thornalley","year":"1998","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.cgh.2006.03.004_bib83","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.cgh.2006.03.004_bib84","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1053\/j.gastro.2004.09.013","article-title":"Hepatocellular carcinoma","volume":"127","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.004_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2005-871192","article-title":"Genetic profiling of human hepatocellular carcinoma","volume":"25","author":"Lee","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2006.03.004_bib86","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.03.004_bib87","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1600-6143.2004.00432.x","article-title":"Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation","volume":"4","author":"Burke","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2006.03.004_bib88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","article-title":"Non-alcoholic steatohepatitis","volume":"44","author":"Cortez-Pinto","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.03.004_bib89","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.004_bib90","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug-induced liver injury","volume":"43","author":"Watkins","year":"2006","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:56:18Z","timestamp":1761540978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356506002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1542356506002308"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.03.004","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Hepatobiliary Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2006.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Gastroenterological Association Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}